The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Spanish Registry on Spontaneous Coronary Artery Dissection (SR-SCAD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03607981
Recruitment Status : Unknown
Verified July 2018 by Fernando Alfonso, Spanish Society of Cardiology.
Recruitment status was:  Recruiting
First Posted : July 31, 2018
Last Update Posted : August 2, 2018
Sponsor:
Information provided by (Responsible Party):
Fernando Alfonso, Spanish Society of Cardiology

Tracking Information
First Submitted Date July 24, 2018
First Posted Date July 31, 2018
Last Update Posted Date August 2, 2018
Actual Study Start Date January 1, 2015
Estimated Primary Completion Date January 1, 2019   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: July 31, 2018)
Predictors of adverse events [ Time Frame: 3 years ]
Clinical, angiographic and imaging predictors of adverse events during follow-up
Original Primary Outcome Measures
 (submitted: July 24, 2018)
  • Predictors of recurrences [ Time Frame: 3 years ]
    Predictors of recurrences of SCAD at follow-up
  • Predictors of adverse events [ Time Frame: 3 years ]
    Clinical, angiographic and imaging predictors of adverse events during follow-up
Change History
Current Secondary Outcome Measures
 (submitted: July 31, 2018)
Predictors of recurrences [ Time Frame: 3 years ]
Predictors of recurrences of SCAD at follow-up
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Spanish Registry on Spontaneous Coronary Artery Dissection
Official Title Spanish Registry on Spontaneous Coronary Artery Dissection
Brief Summary Multicenter observational prospective registry, Spanish nationwide-based, of consecutive patients diagnosed with Spontaneous Coronary Artery Dissection (SCAD)
Detailed Description

Multicenter prospective registry on patients with diagnosis of Spontaneous Coronary Artery Dissection (SCAD). Spanish nationwide based, the aims of the current registry are:

  1. To analyze predisposing factors, potential triggers and associated pathologies of patients presenting with SCAD.
  2. To study the clinical and angiographic presentation of these patients.
  3. To analyze the value of intracoronary diagnostic techniques (OCT, IVUS) and non-invasive imaging techniques in the diagnosis of this pathology.
  4. To better understand the in-hospital clinical evolution and the response to medical treatment or revascularization in these challenging patients, taking into account the angiographic or intravascular imaging morphological characteristics of SCAD and the treatment applied.
  5. To analyze its long-term clinical evolution (adverse cardiovascular events, including recurrence of SCAD).
  6. To identify those factors directly related to prognostic and risk of recurrence.
Study Type Observational [Patient Registry]
Study Design Observational Model: Case-Only
Time Perspective: Prospective
Target Follow-Up Duration 3 Years
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Consecutive patients with a novel diagnosis of Spontaneous Coronary Artery Dissection (SCAD) that meet the inclusion/exclusion criteria.
Condition Spontaneous Coronary Artery Dissection
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Unknown status
Estimated Enrollment
 (submitted: July 24, 2018)
300
Original Estimated Enrollment Same as current
Estimated Study Completion Date January 1, 2020
Estimated Primary Completion Date January 1, 2019   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Those consecutive patients with a novel diagnosis of Spontaneous Coronary Artery Dissection (SCAD) that, after careful information, accepted to sign the informed consent form.

Exclusion Criteria:

  • Those patients unable to provide informed consent.
Sex/Gender
Sexes Eligible for Study: All
Ages Child, Adult, Older Adult
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries Spain
Removed Location Countries  
 
Administrative Information
NCT Number NCT03607981
Other Study ID Numbers SR-SCAD
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement
Plan to Share IPD: Undecided
Current Responsible Party Fernando Alfonso, Spanish Society of Cardiology
Original Responsible Party Same as current
Current Study Sponsor Spanish Society of Cardiology
Original Study Sponsor Same as current
Collaborators Not Provided
Investigators Not Provided
PRS Account Spanish Society of Cardiology
Verification Date July 2018